Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences

Publication | Closed Access

DOI

Citations

References

2013

Year

Jun Ren, Lijun Di, Guohong Song, Jing Yu, Jun Jia, Yuling Zhu, Ying Yan, Hanfang Jiang, Liang Xu, Li Che,

Clinical & Translational Oncology

Metastatic Breast CancerOncologyBreast OncologyImmunologyImmune Checkpoint InhibitorBreast CancerHigh-dose ChemotherapyCancer TreatmentImmunotherapyMedicineAdoptive Cellular Therapy